Pharmaceutical Supply Chain Initiative

United Statespscinitiative.org

Pharmaceutical Supply Chain Initiative (PSCI) is a global, non-profit membership organization of pharmaceutical and healthcare companies that promotes responsible supply chain management. It works to raise standards across the industry by advancing ethics, human and labor rights, health and safety, environmental stewardship, and robust management systems throughout pharmaceutical supply chains.

Read more

PSCI develops and maintains the PSCI Principles, a common set of supplier expectations, and provides tools such as a shared audit program and supplier capability-building resources to harmonize requirements and reduce duplication. Its guidance and assessments are widely used by contract manufacturers and materials suppliers—including producers of active pharmaceutical ingredients, intermediates, excipients, and other chemicals—supporting consistent, transparent, and sustainable practices across the sector.

Projects Pharmaceutical Supply Chain Initiative is involved in

None yet. When a new project in the record names Pharmaceutical Supply Chain Initiative as owner, partner or investor, it shows here.

Active projects close to Pharmaceutical Supply Chain Initiative

Pharmaceutical Supply Chain Initiative in chemical industry news

9 February 2026
WuXi Biologics Earns Third Consecutive EcoVadis Platinum Medal

Recognized for top ESG performance, the company strengthens sustainability with SBTi-approved targets, ISO 20400 certification, and green innovation initiatives.

5 January 2026
WuXi Biologics Earns ISO 20400 for Sustainable Procurement

Achieving ISO 20400, the company integrates sustainability in procurement, enhances supply chain resilience, and commits to net-zero goals with recognized ESG efforts.

22 October 2025
WuXi Biologics Joins Hang Seng Corporate Sustainability Index

Recognized for ESG excellence, the company advances sustainable practices and aligns with global initiatives, earning multiple sustainability accolades and maintaining a strong industry presence.

10 October 2025
WuXi Biologics Earns Third Consecutive MSCI AAA ESG Rating

Recognized for sustainability, WuXi Biologics aligns with UN goals, earns multiple ESG accolades, and supports 864 client projects, emphasizing green technology and responsible practices.